Molecular Mechanisms of Enzalutamide Resistance in Prostate Cancer

PURPOSE OF REVIEW: Compensatory mechanisms leading to increased androgen receptor expression and activity after androgen ablation or anti-androgen treatment have been identified in prostate cancer. After hydroxyflutamide and bicalutamide were used in therapy of prostate cancer over many years, novel...

Descripción completa

Detalles Bibliográficos
Autor principal: Culig, Zoran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Molecular Biology of Prostate Cancer (M Kruithof-de Julio, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700216/
https://www.ncbi.nlm.nih.gov/pubmed/29214142
http://dx.doi.org/10.1007/s40610-017-0079-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700216/
https://www.ncbi.nlm.nih.gov/pubmed/29214142
http://dx.doi.org/10.1007/s40610-017-0079-1

Ejemplares similares